Be a PRO & get up to 50% off on select brands. Explore Now
you are here: HomeNewsBusiness

UK's KPMG boss Bill Michael steps down pending probe into jibes at staff

During a virtual meeting on Monday, members of KPMG's financial services consulting team told Bill Michael about their concerns over potential cuts to pay and the ranking of individuals' performance. Following which Michael told staff to "stop moaning" and to stop "playing the victim card".

February 12, 2021 / 04:02 PM IST
UK's KPMG chairman Bill Michael. (PC-Yahoo Finance)

UK's KPMG chairman Bill Michael. (PC-Yahoo Finance)

The UK chairman of KPMG has stepped down pending an internal investigation after he told staff at the global accountancy firm to "stop moaning" about working conditions during the coronavirus pandemic, a spokesperson said Wednesday.

The Financial Times reported that during a virtual meeting on Monday, members of KPMG's financial services consulting team told Bill Michael about their concerns over potential cuts to pay and the ranking of individuals' performance.

Exclusive: Swiggy Auditor KPMG points out discrepancy in accounting

Michael told staff to "stop moaning" and to stop "playing the victim card", according to the FT, citing employees.

The chairman apologised in a statement relayed to AFP, but the firm confirmed he was also stepping down for now.


COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more

"Following the meeting on 8 February, the firm initiated an independent investigation into the alleged comments in accordance with its usual procedures," a KPMG UK spokesperson said.

"Mr Michael has decided to step aside from his duties as chair while the investigation is under way," the spokesperson said, declining to comment further.

KPMG is one of Britain's so-called Big Four accountancy groups along with Deloitte, EY and PWC.

They are set for a shake-up as UK authorities want the industry to separate their audit and more lucrative consulting activities, while increasing oversight and competition following allegations of malpractice.
first published: Feb 12, 2021 04:02 pm

stay updated

Get Daily News on your Browser
Enjoying Moneycontrol?

How about a quick survey to help us improve our services?

Ok, sure

Maybe next time!